Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages

Di Lu1, Zhen Ni1, Xiguang Liu1

  • 1Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Insights

Programmed cell death protein 1 (PD-1) and its ligand PD-L1 play key roles in immunotherapy beyond T cells. This review focuses on their functions within macrophages, offering insights for improved cancer treatments.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Programmed cell death protein 1 (PD-1) and its ligand PD-L1 are crucial in immune regulation.
  • Their roles extend beyond T lymphocytes to various cell types, including macrophages.
  • Understanding PD-1/PD-L1 in macrophages is vital for advancing immunotherapy.

Purpose of the Study:

  • To review recent research on the roles of PD-1 and PD-L1 in macrophages.
  • To deepen the understanding of PD-1/PD-L1 interactions within the macrophage context.
  • To provide insights for enhancing anti-PD-1/PD-L1 immunotherapy strategies.

Main Methods:

  • Literature review of recent studies on PD-1/PD-L1 in macrophages.
  • Synthesis of findings regarding PD-1/PD-L1 expression and function in macrophages.
  • Analysis of the implications for immunotherapy.

Main Results:

  • PD-1 and PD-L1 are expressed on various cells, including macrophages.
  • PD-1/PD-L1 signaling influences macrophage functions relevant to the immune response.
  • Emerging evidence highlights their significance in the tumor microenvironment.

Conclusions:

  • PD-1/PD-L1 signaling in macrophages presents a promising target for cancer immunotherapy.
  • Further research into macrophage-specific PD-1/PD-L1 roles can refine therapeutic approaches.
  • This understanding may lead to improved patient outcomes in immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K